Human Diseases and Recent Biotechnology Breakthroughs in Curbing Diseases

Author:

Villagómez-Guzmán Ana K.1,Valencia Quiroz Israel2

Affiliation:

1. Laboratory of Natural Products Bioactivity, UBIPRO, Superior Studies Faculty (FES)-Iztacala, National Autonomous University of Mexico (UNAM), Tlalnepantla de Baz, México State, 54090, México

2. Phytochemistry Laboratory, UBIPRO, Superior Studies Faculty (FES)-Iztacala, National Autonomous University of Mexico (UNAM), Tlalnepantla de Baz, México State, 54090, México

Abstract

Medical biotechnology represents a field in continuous progress and today has revolutionized how illnesses are diagnosed and treated. A look at the latest medical biotechnological breakthroughs shows how biotechnology innovations are changing medicine. Recently, we saw how biotechnology affected efforts to combat the coronavirus disease 2019 (COVID-19) pandemic on the world's health. The scientific community has been working assiduously to develop effective treatments for the prevention and management of other diseases, such as cancer, human immunodeficiency virus (HIV), cardiovascular disease, diabetes mellitus, and neurodegenerative disorders such as Alzheimer's disease, along with other dementia variants that stand out among the leading causes of mortality worldwide. This effort has recently resulted in the development of RNA vaccines. Some of the most promising biotechnological developments include gene therapy to alter an individual's genetic makeup through diverse techniques, immunotherapeutic methods that bolster the body's natural immune defense mechanisms, and precision medicine strategies in which treatment is personalized to a patient's genetic profile. This chapter provides an overview of the most prevalent and deadly human diseases with a focus on recent biotechnological breakthroughs.<br>

Publisher

BENTHAM SCIENCE PUBLISHERS

Reference74 articles.

1. Farooq Z, Rashid S, Mahmood S, Mahmood A, Anwar M. The Advent of Medical Biotechnology. In: Anwar M, Rather RA, Farooq Z, Eds. Fundamentals and Advances in Medical Biotechnology Switzerland: Springer Cham 2022; pp.1-20.

2. Liao C.; Xiao S.; Wang X.; Bench-to-bedside: Translational development landscape of biotechnology in healthcare. Health Sci Rev 2023,7,100097

3. Wong E.; Bertin N.; Hebrard M.; Tirado-Magallanes R.; Bellis C.; Lim W.K.; Chua C.Y.; Tong P.M.L.; Chua R.; Mak K.; Lim T.M.; Cheong W.Y.; Thien K.E.; Goh K.T.; Chai J.F.; Lee J.; Sung J.J.Y.; Wong T.Y.; Chin C.W.L.; Gluckman P.D.; Goh L.L.; Ban K.H.K.; Tan T.W.; Van Dam R.M.; Teo Y.Y.; Loh M.; Eillot P.; Lee E.S.; Ngeow J.; Riboli E.; Dalan R.; Kassam I.; Lakshmanan L.N.; Lim T.H.; Ng H.K.; Mina T.; Tay D.; Sabanayagam C.; Tham Y.C.; Rim T.; Aung T.; Chee M.L.; Li H.; Chee M.L.; Yeo K.K.; Cook S.A.; Pua C.J.; Yang C.; Chong Y.S.; Eriksson J.G.; Tan K.H.; Yap F.; Lim C.W.; Tsai P.K.; Chew W.J.; Sim W.C.; Toh L.G.; Lin C.B.; Sia Y.Y.; Koh T.H.; Meah W.Y.; Tan J.H.J.; Jeyakani J.; Ow J.; Ang S.; Malik A.J.; Kenanov D.; Sim X.; Cheng C-Y.; Davila S.; Karnani N.; Leong K.P.; Liu J.; Prabhakar S.; Maurer-Stroh S.; Verma C.S.; Krishnaswamy P.; Goh R.S.M.; Chia I.; Ho C.; Low D.; Virabhak S.; Yong J.; Zheng W.; Seow S.W.; Seck Y.K.; Koh M.; Chambers J.C.; Tai E.S.; Tan P.; The Singapore national precision medicine strategy. Nat Genet 2023,55(2),178-186

4. Naithani N.; Sinha S.; Misra P.; Vasudevan B.; Sahu R.; Precision medicine: Concept and tools. Med J Armed Forces India 2021,77(3),249-257

5. Yu J.; Li T.; Zhu J.; Gene therapy strategies targeting aging-related diseases. Aging Dis 2023,14(2),398-417

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3